In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 5.82 million shares changing hands with its beta currently measuring 1.80. Company’s recent per share price level of $0.56 trading at -$0.04 or -6.65% at ring of the bell on the day assigns it a market valuation of $2.84M. That closing price of QNRX’s stock is at a discount of -1003.57% from its 52-week high price of $6.18 and is indicating a premium of 14.29% from its 52-week low price of $0.48. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.42 million shares which gives us an average trading volume of 2.93 million if we extend that period to 3-months.
For Quoin Pharmaceuticals Ltd ADR (QNRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Upright in the red during last session for losing -6.65%, in the last five days QNRX remained trading in the red while hitting it’s week-highest on Thursday, 12/12/24 when the stock touched $0.56 price level, adding 23.29% to its value on the day. Quoin Pharmaceuticals Ltd ADR’s shares saw a change of -88.53% in year-to-date performance and have moved -26.95% in past 5-day. Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) showed a performance of -6.25% in past 30-days. Number of shares sold short was 19172.0 shares which calculate 0.2 days to cover the short interests.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Statistics highlight that Quoin Pharmaceuticals Ltd ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -9.84% of value to its shares in past 6 months, showing an annual growth rate of 78.73% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -194.79% during past 5 years.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
Insiders are in possession of 2.45% of company’s total shares while institution are holding 5.89 percent of that, with stock having share float percentage of 6.03%. Investors also watch the number of corporate investors in a company very closely, which is 5.89% institutions for Quoin Pharmaceuticals Ltd ADR that are currently holding shares of the company.
